CLOV vs. SKLZ, ALHC, MGX, MODV, AXGN, CERS, AVIR, GLUE, NAUT, and TERN
Should you be buying Clover Health Investments stock or one of its competitors? The main competitors of Clover Health Investments include Skillz (SKLZ), Alignment Healthcare (ALHC), Metagenomi (MGX), ModivCare (MODV), AxoGen (AXGN), Cerus (CERS), Atea Pharmaceuticals (AVIR), Monte Rosa Therapeutics (GLUE), Nautilus Biotechnology (NAUT), and Terns Pharmaceuticals (TERN).
Skillz (NYSE:SKLZ) and Clover Health Investments (NASDAQ:CLOV) are both small-cap consumer discretionary companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.
Skillz has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Skillz, indicating that it is currently the more affordable of the two stocks.
Skillz presently has a consensus price target of $11.50, suggesting a potential upside of 84.59%. Clover Health Investments has a consensus price target of $1.50, suggesting a potential upside of 123.88%. Given Skillz's higher possible upside, analysts plainly believe Clover Health Investments is more favorable than Skillz.
Clover Health Investments has a net margin of -10.49% compared to Clover Health Investments' net margin of -74.59%. Clover Health Investments' return on equity of -50.98% beat Skillz's return on equity.
19.4% of Skillz shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 22.7% of Skillz shares are owned by insiders. Comparatively, 21.8% of Clover Health Investments shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Skillz has a beta of 2.83, meaning that its stock price is 183% more volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 1.84, meaning that its stock price is 84% more volatile than the S&P 500.
In the previous week, Clover Health Investments had 5 more articles in the media than Skillz. MarketBeat recorded 5 mentions for Clover Health Investments and 0 mentions for Skillz. Clover Health Investments' average media sentiment score of 0.00 beat Skillz's score of -0.20 indicating that Skillz is being referred to more favorably in the media.
Skillz received 14 more outperform votes than Clover Health Investments when rated by MarketBeat users. Likewise, 54.69% of users gave Skillz an outperform vote while only 39.62% of users gave Clover Health Investments an outperform vote.
Summary
Skillz beats Clover Health Investments on 11 of the 18 factors compared between the two stocks.
Get Clover Health Investments News Delivered to You Automatically
Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Clover Health Investments Competitors List
Related Companies and Tools
